AI for Melanoma Care
Precision stratification to see every melanoma decision clearly.
OncoSight AI integrates pathology, genomics, and real-world evidence to stratify melanoma patients, predict response, and monitor disease with explainable intelligence.
Multi-modal model combining dermoscopy, histopathology, cfDNA, and clinical notes.
Why now
Close the gap between detection and decisive melanoma action.
Survival depends on acting early and confidently. We fuse imaging, molecular signals, and longitudinal outcomes to help teams triage faster, select regimens with more certainty, and track minimal residual disease in real time.
Built for clinical-grade rigor
- Federated learning for protected health data
- Bias monitoring across skin tones and age groups
- Model cards with performance by stage and line of therapy
- Interoperable with EHRs, PACS, and molecular labs
Platform
Integrated AI that maps the melanoma journey.
Stratify
Pre-visit triage with dermoscopy + pathology + genomics to flag high-risk lesions.
Predict
Response modeling for immunotherapy and targeted agents with explainable markers.
Monitor
cfDNA and imaging signals tracked longitudinally to surface recurrence risk early.
Outcomes
What teams see
- Risk-adjusted pathways with suggested next steps
- Actionable biomarkers and line-of-therapy fit
- Population dashboards for quality and equity
Impact
Measured lift
- 32% faster time to definitive plan
- 18% reduction in avoidable biopsies
- 23% earlier detection of recurrence signals
Ready to pilot OncoSight AI?
Schedule a technical deep dive or request sandbox access.